Patients using some types of systemic anti-hypertensive medications should be monitored for glaucoma. Patients treated with dihydropyridine calcium channel blockers are more likely to develop ...

Calcium channel blockers were first identified and approved as medications in the previous half-century, and have emerged as major therapies for cardiovascular disorders. These latest findings could ...

There have been a number of case reports describing patients in whom the onset of depression followed the institution of treatment with calcium channel blockers. [1, 2, 3] However, studies ...

Diverticulosis is a condition that affects the gut, which is the long tube in your body that helps digest food. In this ...

The Calcium Channel Blockers Market was valued at US$ 14.5 Bn in 2022 and is projected to grow at a CAGR of 5.7% from 2023 to 2031, reaching more than US$ 24.0 Bn by 2031. Rising geriatric populations ...

The association of calcium channel blockers with peripheral edema is well known. While vasodilating calcium channel blockers—amlodipine, felodipine, and nifedipine—are frequently associated ...